Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06237_nanopub.RArlsHq_6j5Jtd4uzrNrDfY287lJThijuiVDLVaVrsa_E#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- drugbank:DB06237 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06237 label "Avanafil [drugbank:DB06237]" assertion.
- drugbank:DB06237 seeAlso DB06237 assertion.
- drugbank:DB06237 seeAlso avanafil.html assertion.
- drugbank:DB06237 seeAlso stendra-drug.htm assertion.
- drugbank:DB06237 identifier "drugbank:DB06237" assertion.
- drugbank:DB06237 description "Avanafil is a new phosphodiesterase-5 inhibitor that is faster acting and more selective than other drugs belonging to the same class. Chemically, it is a derivative of pyrimidine and is only available as the S-enantiomer. FDA approved on April 27, 2012." assertion.
- drugbank:DB06237 title "Avanafil" assertion.
- drugbank:DB06237 bio2rdf_vocabulary:identifier "DB06237" assertion.
- drugbank:DB06237 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06237 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06237" assertion.
- drugbank:DB06237 bio2rdf_vocabulary:x-identifiers.org DB06237 assertion.
- drugbank:DB06237 drugbank_vocabulary:drugbank-id "DB06237" assertion.
- drugbank:DB06237 drugbank_vocabulary:x-cas cas:330784-47-9 assertion.
- drugbank:DB06237 drugbank_vocabulary:x-ahfs ahfs:24:12.12 assertion.
- drugbank:DB06237 drugbank_vocabulary:x-chebi chebi:66876 assertion.
- drugbank:DB06237 drugbank_vocabulary:x-kegg kegg:D03217 assertion.
- drugbank:DB06237 drugbank_vocabulary:x-wikipedia wikipedia:Avanafil assertion.
- drugbank:DB06237 drugbank_vocabulary:x-ndc ndc:62541-303-30 assertion.